Pacira BioSciences Inc (PCRX)
27.21
-0.11
(-0.40%)
USD |
NASDAQ |
May 03, 16:00
27.22
+0.01
(+0.04%)
After-Hours: 20:00
Pacira BioSciences 1 Year Total Returns (Daily): -36.90% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -36.90% |
May 02, 2024 | -41.18% |
May 01, 2024 | -42.17% |
April 30, 2024 | -42.07% |
April 29, 2024 | -42.51% |
April 26, 2024 | -40.25% |
April 25, 2024 | -42.53% |
April 24, 2024 | -43.43% |
April 23, 2024 | -43.56% |
April 22, 2024 | -45.05% |
April 19, 2024 | -42.18% |
April 18, 2024 | -39.96% |
April 17, 2024 | -38.13% |
April 16, 2024 | -36.70% |
April 15, 2024 | -37.50% |
April 12, 2024 | -35.87% |
April 11, 2024 | -34.33% |
April 10, 2024 | -33.10% |
April 09, 2024 | -31.98% |
April 08, 2024 | -32.08% |
April 05, 2024 | -31.13% |
April 04, 2024 | -31.28% |
April 03, 2024 | -29.88% |
April 02, 2024 | -30.14% |
April 01, 2024 | -28.57% |
Date | Value |
---|---|
March 28, 2024 | -26.79% |
March 27, 2024 | -27.53% |
March 26, 2024 | -27.16% |
March 25, 2024 | -25.32% |
March 22, 2024 | -27.10% |
March 21, 2024 | -27.28% |
March 20, 2024 | -24.34% |
March 19, 2024 | -25.37% |
March 18, 2024 | -25.83% |
March 15, 2024 | -25.28% |
March 14, 2024 | -25.36% |
March 13, 2024 | -21.53% |
March 12, 2024 | -23.70% |
March 11, 2024 | -22.55% |
March 08, 2024 | -20.66% |
March 07, 2024 | -24.18% |
March 06, 2024 | -26.29% |
March 05, 2024 | -29.99% |
March 04, 2024 | -30.56% |
March 01, 2024 | -33.47% |
February 29, 2024 | -30.19% |
February 28, 2024 | -29.74% |
February 27, 2024 | -27.12% |
February 26, 2024 | -27.46% |
February 23, 2024 | -28.05% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-49.04%
Minimum
Apr 10 2023
146.5%
Maximum
Mar 23 2021
0.57%
Average
-4.32%
Median
Jan 08 2024
1 Year Total Returns (Daily) Benchmarks
Dynavax Technologies Corp | 6.53% |
Arbutus Biopharma Corp | 7.97% |
Chimerix Inc | -15.67% |
Karyopharm Therapeutics Inc | -69.13% |
FibroGen Inc | -93.15% |